| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | LGMN KIF6 SHROOM3 IQGAP2 MAP2 DISC1 SPTAN1 SPTBN1 SPTBN2 EML6 OBSCN GBP2 NEB MPRIP CEP350 NF1 ABITRAM MACF1 DAAM2 MYH15 AATF CEP295 KIF5A GOLGA8A WASF1 | 9.30e-06 | 1099 | 173 | 25 | GO:0008092 |
| GeneOntologyMolecularFunction | ATP-dependent activity | KIF6 ERCC6 ABCB5 DNAH2 DHX57 MCM5 DDX56 CHD7 ABCA7 NLRP3 DNAH1 MLH3 IQCA1 ACSBG1 MACF1 MYH15 KIF5A | 2.56e-05 | 614 | 173 | 17 | GO:0140657 |
| GeneOntologyMolecularFunction | actin filament binding | SHROOM3 IQGAP2 SPTAN1 SPTBN1 SPTBN2 NEB MPRIP ABITRAM MACF1 MYH15 | 2.99e-05 | 227 | 173 | 10 | GO:0051015 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | KIF6 ERCC6 ABCB5 DNAH2 DHX57 MCM5 DDX56 CHD7 ABCA7 NLRP3 MLH3 IQCA1 MACF1 KIF5A | 3.16e-05 | 441 | 173 | 14 | GO:0016887 |
| GeneOntologyMolecularFunction | methionine adenosyltransferase activity | 7.46e-05 | 2 | 173 | 2 | GO:0004478 | |
| GeneOntologyMolecularFunction | actin binding | SHROOM3 IQGAP2 MAP2 SPTAN1 SPTBN1 SPTBN2 GBP2 NEB MPRIP ABITRAM MACF1 DAAM2 MYH15 WASF1 | 7.69e-05 | 479 | 173 | 14 | GO:0003779 |
| GeneOntologyMolecularFunction | testosterone 16-alpha-hydroxylase activity | 4.43e-04 | 4 | 173 | 2 | GO:0008390 | |
| GeneOntologyMolecularFunction | endopeptidase activator activity | 5.59e-04 | 19 | 173 | 3 | GO:0061133 | |
| GeneOntologyMolecularFunction | testosterone 6-beta-hydroxylase activity | 7.34e-04 | 5 | 173 | 2 | GO:0050649 | |
| GeneOntologyMolecularFunction | vitamin D 23-hydroxylase activity | 7.34e-04 | 5 | 173 | 2 | GO:0062179 | |
| GeneOntologyMolecularFunction | 1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity | 7.34e-04 | 5 | 173 | 2 | GO:0062181 | |
| GeneOntologyMolecularFunction | calmodulin binding | 9.11e-04 | 230 | 173 | 8 | GO:0005516 | |
| GeneOntologyMolecularFunction | vitamin D3 25-hydroxylase activity | 1.09e-03 | 6 | 173 | 2 | GO:0030343 | |
| GeneOntologyMolecularFunction | MAP kinase kinase kinase kinase activity | 1.09e-03 | 6 | 173 | 2 | GO:0008349 | |
| GeneOntologyMolecularFunction | vitamin D 24-hydroxylase activity | 1.09e-03 | 6 | 173 | 2 | GO:0070576 | |
| GeneOntologyMolecularFunction | microtubule binding | 1.50e-03 | 308 | 173 | 9 | GO:0008017 | |
| GeneOntologyMolecularFunction | vitamin D 25-hydroxylase activity | 1.52e-03 | 7 | 173 | 2 | GO:0070643 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor | 2.02e-03 | 8 | 173 | 2 | GO:0033695 | |
| GeneOntologyMolecularFunction | caffeine oxidase activity | 2.02e-03 | 8 | 173 | 2 | GO:0034875 | |
| GeneOntologyMolecularFunction | estrogen 2-hydroxylase activity | 2.02e-03 | 8 | 173 | 2 | GO:0101021 | |
| GeneOntologyCellularComponent | spectrin | 4.75e-05 | 9 | 176 | 3 | GO:0008091 | |
| GeneOntologyCellularComponent | methionine adenosyltransferase complex | 2.10e-04 | 3 | 176 | 2 | GO:0048269 | |
| GeneOntologyCellularComponent | cell cortex | FNBP1 SHROOM3 IQGAP2 GLRX3 SPTAN1 SPTBN1 SPTBN2 FRYL TRIP10 MACF1 PHLDB2 | 3.20e-04 | 371 | 176 | 11 | GO:0005938 |
| Domain | SH3 | FNBP1 CACNB1 CACNB4 SPTAN1 OBSCN SAMSN1 NEB TRIP10 MACF1 UBASH3B | 3.10e-05 | 216 | 171 | 10 | PS50002 |
| Domain | SH3_domain | FNBP1 CACNB1 CACNB4 SPTAN1 OBSCN SAMSN1 NEB TRIP10 MACF1 UBASH3B | 3.63e-05 | 220 | 171 | 10 | IPR001452 |
| Domain | Spectrin | 5.24e-05 | 23 | 171 | 4 | PF00435 | |
| Domain | CCDC74 | 8.33e-05 | 2 | 171 | 2 | IPR033226 | |
| Domain | S-AdoMet_synt_N | 8.33e-05 | 2 | 171 | 2 | PF00438 | |
| Domain | DUF4061 | 8.33e-05 | 2 | 171 | 2 | PF13270 | |
| Domain | CCDC74_C | 8.33e-05 | 2 | 171 | 2 | IPR029422 | |
| Domain | DUF4061 | 8.33e-05 | 2 | 171 | 2 | IPR025271 | |
| Domain | S-AdoMet_synthetase | 8.33e-05 | 2 | 171 | 2 | IPR002133 | |
| Domain | CCDC74_C | 8.33e-05 | 2 | 171 | 2 | PF14917 | |
| Domain | S-AdoMet_synt_M | 8.33e-05 | 2 | 171 | 2 | PF02772 | |
| Domain | S-AdoMet_synt_C | 8.33e-05 | 2 | 171 | 2 | PF02773 | |
| Domain | ADOMET_SYNTHASE_CS | 8.33e-05 | 2 | 171 | 2 | IPR022631 | |
| Domain | S-AdoMet_synt_C | 8.33e-05 | 2 | 171 | 2 | IPR022630 | |
| Domain | S-AdoMet_synthetase_sfam | 8.33e-05 | 2 | 171 | 2 | IPR022636 | |
| Domain | S-AdoMet_synt_central | 8.33e-05 | 2 | 171 | 2 | IPR022629 | |
| Domain | S-AdoMet_synt_N | 8.33e-05 | 2 | 171 | 2 | IPR022628 | |
| Domain | ADOMET_SYNTHASE_1 | 8.33e-05 | 2 | 171 | 2 | PS00376 | |
| Domain | ADOMET_SYNTHASE_2 | 8.33e-05 | 2 | 171 | 2 | PS00377 | |
| Domain | Spectrin_repeat | 1.35e-04 | 29 | 171 | 4 | IPR002017 | |
| Domain | SH3 | 1.73e-04 | 216 | 171 | 9 | SM00326 | |
| Domain | SPEC | 2.00e-04 | 32 | 171 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.00e-04 | 32 | 171 | 4 | IPR018159 | |
| Domain | RHIM | 2.49e-04 | 3 | 171 | 2 | PF12721 | |
| Domain | RHIM_dom | 2.49e-04 | 3 | 171 | 2 | IPR025735 | |
| Domain | VDCC_L_bsu | 4.94e-04 | 4 | 171 | 2 | IPR000584 | |
| Domain | Spectrin_bsu | 4.94e-04 | 4 | 171 | 2 | IPR016343 | |
| Domain | MAPKKKK | 4.94e-04 | 4 | 171 | 2 | IPR021160 | |
| Domain | VGCC_beta4Aa_N | 4.94e-04 | 4 | 171 | 2 | PF12052 | |
| Domain | SH3_1 | 7.96e-04 | 164 | 171 | 7 | PF00018 | |
| Domain | Cyt_P450_E_grp-II | 8.18e-04 | 5 | 171 | 2 | IPR002402 | |
| Domain | TPR_REGION | 8.25e-04 | 165 | 171 | 7 | PS50293 | |
| Domain | TPR | 8.25e-04 | 165 | 171 | 7 | PS50005 | |
| Domain | Ank_2 | ANKRD37 ANKRD20A2P ANKRD20A3P SNCAIP ANKRD20A4P ANKDD1B TRPV6 ANKRD20A1 | 8.37e-04 | 215 | 171 | 8 | PF12796 |
| Domain | ACTININ_2 | 1.17e-03 | 23 | 171 | 3 | PS00020 | |
| Domain | ACTININ_1 | 1.17e-03 | 23 | 171 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 1.17e-03 | 23 | 171 | 3 | IPR001589 | |
| Domain | - | 1.22e-03 | 6 | 171 | 2 | 2.40.50.90 | |
| Domain | Cyt_P450_E_CYP3A | 1.22e-03 | 6 | 171 | 2 | IPR008072 | |
| Domain | Staphylococal_nuclease_OB-fold | 1.22e-03 | 6 | 171 | 2 | IPR016071 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 2.12e-05 | 63 | 127 | 6 | M11187 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 8.18e-05 | 10 | 127 | 3 | MM15112 | |
| Pathway | REACTOME_TRP_CHANNELS | 1.09e-04 | 28 | 127 | 4 | MM14943 | |
| Pathway | REACTOME_TRP_CHANNELS | 1.09e-04 | 28 | 127 | 4 | M27241 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 1.64e-04 | 31 | 127 | 4 | M877 | |
| Pubmed | COL5A1 SPTAN1 SPTBN1 SPTBN2 BAZ1B SRP72 DHX57 MCM5 DDX56 FRYL CHD7 UBE2O NF1 GEMIN4 MACF1 AATF PCM1 TP53BP1 SON | 2.53e-09 | 653 | 185 | 19 | 22586326 | |
| Pubmed | CACNB1 CACNB4 SHROOM3 IQGAP2 SPTAN1 SPTBN1 SPTBN2 HECTD4 CHD7 MPRIP UBE2O NF1 TRIM67 MACF1 KIF5A UBASH3B GOLGA8A WASF1 PCM1 TP53BP1 PHLDB2 | 5.30e-08 | 963 | 185 | 21 | 28671696 | |
| Pubmed | 1.48e-07 | 3 | 185 | 3 | 32321638 | ||
| Pubmed | SCN11A IQGAP2 PCDHGB3 ABCB5 SPTAN1 SPTBN1 SPTBN2 EML6 DNAH2 SRP72 DHX57 MCM5 ZFC3H1 NEB OGDH RINT1 TRIM67 VPS13A MACF1 MYH15 AATF CEP295 KIF5A MAPK6 PCDHGC3 | 2.17e-07 | 1442 | 185 | 25 | 35575683 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | ERCC6 MAP4K3 MAT2A SPTAN1 SPTBN1 TTC27 BAZ1B DHX57 MCM5 DDX56 CHD7 POLR3A MPRIP RLF NF1 CLIC1 MAP4K5 GEMIN4 MACF1 AATF PSME3 TP53BP1 PHLDB2 SON | 2.57e-07 | 1353 | 185 | 24 | 29467282 |
| Pubmed | BRPF3 ERCC6 TRIM4 ZNF460 TTC27 BAZ1B DDX56 ABCA7 MLH3 COQ8A CCNB3 ZFP91 MACF1 MAIP1 CEP295 LRRC8B FKBP8 UNC80 PCM1 PHLDB2 SON | 5.99e-07 | 1116 | 185 | 21 | 31753913 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RALGAPA1 SHROOM3 MAP2 SEC24A SPTAN1 SPTBN1 FRYL MAP3K6 RSRC1 MPRIP CEP350 NF1 SLF2 TET1 RNF10 MACF1 PCM1 PHLDB2 | 9.19e-07 | 861 | 185 | 18 | 36931259 |
| Pubmed | 1.47e-06 | 5 | 185 | 3 | 34942311 | ||
| Pubmed | TRPM6 LARGE2 FNBP1 LGMN IQGAP2 MAP4K3 SPTBN1 OBSCN BAZ1B FRYL CHD7 MTMR6 COQ8A TET1 RBPJ MACF1 AATF CEP295 ESPL1 TP53BP1 | 1.53e-06 | 1084 | 185 | 20 | 11544199 | |
| Pubmed | 1.60e-06 | 151 | 185 | 8 | 17043677 | ||
| Pubmed | PALD1 COL5A1 IQGAP2 GLRX3 SPTAN1 SPTBN1 SPTBN2 TTC27 SRP72 DHX57 MCM5 DDX56 OGDH POLR3A DNAAF5 RINT1 COQ8A CLIC1 GEMIN4 MAIP1 PSME3 FKBP8 PCM1 | 2.76e-06 | 1440 | 185 | 23 | 30833792 | |
| Pubmed | ST3GAL1 and βII-spectrin pathways control CAR T cell migration to target tumors. | 2.93e-06 | 6 | 185 | 3 | 37069398 | |
| Pubmed | RIP1-driven autoinflammation targets IL-1α independently of inflammasomes and RIP3. | 2.93e-06 | 6 | 185 | 3 | 23708968 | |
| Pubmed | 4.32e-06 | 21 | 185 | 4 | 16079250 | ||
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 4.49e-06 | 231 | 185 | 9 | 16452087 | |
| Pubmed | RNA viruses promote activation of the NLRP3 inflammasome through a RIP1-RIP3-DRP1 signaling pathway. | 8.13e-06 | 8 | 185 | 3 | 25326752 | |
| Pubmed | 8.13e-06 | 8 | 185 | 3 | 31869420 | ||
| Pubmed | Expression of testicular germ cell genes identified by differential display analysis. | 8.13e-06 | 8 | 185 | 3 | 12634303 | |
| Pubmed | cFLIPL protects macrophages from LPS-induced pyroptosis via inhibition of complex II formation. | 8.13e-06 | 8 | 185 | 3 | 32193329 | |
| Pubmed | Caspase-8 scaffolding function and MLKL regulate NLRP3 inflammasome activation downstream of TLR3. | 8.13e-06 | 8 | 185 | 3 | 26104484 | |
| Pubmed | FNBP1 DNAH2 CHD7 NEB CEP350 NF1 TMTC3 COQ8A VPS13A AATF MAIP1 CEP295 WASF1 TARBP1 | 9.13e-06 | 638 | 185 | 14 | 31182584 | |
| Pubmed | 9.75e-06 | 322 | 185 | 10 | 26514267 | ||
| Pubmed | Caspase-8 and RIP kinases regulate bacteria-induced innate immune responses and cell death. | 1.21e-05 | 9 | 185 | 3 | 24799678 | |
| Pubmed | 1.27e-05 | 332 | 185 | 10 | 37433992 | ||
| Pubmed | 1.44e-05 | 28 | 185 | 4 | 33953184 | ||
| Pubmed | RALGAPA1 TACO1 SHROOM3 MAP2 SPTAN1 SPTBN1 SPTBN2 BAZ1B ZFC3H1 OGDH MPRIP RINT1 UBE2O TMTC3 MAP4K5 VPS13A MACF1 MRPL40 FKBP8 ESPL1 PCM1 TP53BP1 | 1.52e-05 | 1487 | 185 | 22 | 33957083 | |
| Pubmed | TAK1 restricts spontaneous NLRP3 activation and cell death to control myeloid proliferation. | 1.73e-05 | 10 | 185 | 3 | 29500178 | |
| Pubmed | Cell organization, growth, and neural and cardiac development require αII-spectrin. | 1.73e-05 | 10 | 185 | 3 | 22159418 | |
| Pubmed | Evolutionary history and genome organization of DUF1220 protein domains. | 1.73e-05 | 10 | 185 | 3 | 22973535 | |
| Pubmed | 2.15e-05 | 156 | 185 | 7 | 22952844 | ||
| Pubmed | Brain proteins interacting with the tetramerization region of non-erythroid alpha spectrin. | 2.37e-05 | 11 | 185 | 3 | 17607528 | |
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 26496737 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 32247850 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 28176780 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 20715157 | ||
| Pubmed | Positive and negative phosphorylation regulates RIP1- and RIP3-induced programmed necrosis. | 2.81e-05 | 2 | 185 | 2 | 24059293 | |
| Pubmed | The Role of RIPK1/3 in Adult Onset Still's Disease Patients With Liver Damage: A Preliminary Study. | 2.81e-05 | 2 | 185 | 2 | 33329521 | |
| Pubmed | Mosaic composition of RIP1-RIP3 signalling hub and its role in regulating cell death. | 2.81e-05 | 2 | 185 | 2 | 35256774 | |
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 23584955 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 22318685 | ||
| Pubmed | Necroptosis in cardiovascular disease - a new therapeutic target. | 2.81e-05 | 2 | 185 | 2 | 29524460 | |
| Pubmed | The anti-tumor effect of shikonin on osteosarcoma by inducing RIP1 and RIP3 dependent necroptosis. | 2.81e-05 | 2 | 185 | 2 | 24314238 | |
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 25674205 | ||
| Pubmed | RIP1 kinase mediates angiogenesis by modulating macrophages in experimental neovascularization. | 2.81e-05 | 2 | 185 | 2 | 31685620 | |
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 34281454 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 17512409 | ||
| Pubmed | Identification of a mouse brain beta-spectrin cDNA and distribution of its mRNA in adult tissues. | 2.81e-05 | 2 | 185 | 2 | 1742606 | |
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 29749642 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 27258786 | ||
| Pubmed | The diverse role of RIP kinases in necroptosis and inflammation. | 2.81e-05 | 2 | 185 | 2 | 26086143 | |
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 25015821 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 25327580 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 15837514 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 34404478 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 27748372 | ||
| Pubmed | CHD7 and 53BP1 regulate distinct pathways for the re-ligation of DNA double-strand breaks. | 2.81e-05 | 2 | 185 | 2 | 33188175 | |
| Pubmed | Divergent effects of RIP1 or RIP3 blockade in murine models of acute liver injury. | 2.81e-05 | 2 | 185 | 2 | 25950489 | |
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 20360304 | ||
| Pubmed | RIP3 dependent NLRP3 inflammasome activation is implicated in acute lung injury in mice. | 2.81e-05 | 2 | 185 | 2 | 30126430 | |
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 31234428 | ||
| Pubmed | Spectrin-actin interaction is required for neurite extension in NB 2a/dl neuroblastoma cells. | 2.81e-05 | 2 | 185 | 2 | 8776664 | |
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 29448301 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 33924766 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 24733486 | ||
| Pubmed | Caspase-3/7-mediated Cleavage of β2-spectrin is Required for Acetaminophen-induced Liver Damage. | 2.81e-05 | 2 | 185 | 2 | 26884715 | |
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 21098270 | ||
| Pubmed | CCDC74A/B are K-fiber crosslinkers required for chromosomal alignment. | 2.81e-05 | 2 | 185 | 2 | 31521166 | |
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 38161978 | ||
| Pubmed | Evaluation of RIP1K and RIP3K expressions in the malignant and benign breast tumors. | 2.81e-05 | 2 | 185 | 2 | 26749282 | |
| Pubmed | Frequency and amplitude control of cortical oscillations by phosphoinositide waves. | 2.81e-05 | 2 | 185 | 2 | 26751515 | |
| Pubmed | RIP3 S-nitrosylation contributes to cerebral ischemic neuronal injury. | 2.81e-05 | 2 | 185 | 2 | 26319693 | |
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 29686269 | ||
| Pubmed | RIPK1 and RIPK3 regulate TNFα-induced β-cell death in concert with caspase activity. | 2.81e-05 | 2 | 185 | 2 | 36030035 | |
| Pubmed | Molecular Pathways: The Necrosome-A Target for Cancer Therapy. | 2.81e-05 | 2 | 185 | 2 | 27932417 | |
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 31268597 | ||
| Pubmed | Expression of Protein Kinases RIPK-1 and RIPK-3 in Mouse and Human Hair Follicle. | 2.81e-05 | 2 | 185 | 2 | 33119828 | |
| Pubmed | Cell Death and Inflammation - A Vital but Dangerous Liaison. | 2.81e-05 | 2 | 185 | 2 | 31003931 | |
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 35781632 | ||
| Pubmed | RIPK3 and RIPK1 gene expression in pterygium: unveiling molecular insights into pathogenesis. | 2.81e-05 | 2 | 185 | 2 | 38630344 | |
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 19455170 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 27076759 | ||
| Pubmed | Characterization of a new beta-spectrin gene which is predominantly expressed in brain. | 2.81e-05 | 2 | 185 | 2 | 9675416 | |
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 11734559 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 32061523 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 9421237 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 14500989 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 30192300 | ||
| Pubmed | Activation of MAT2A-RIP1 signaling axis reprograms monocytes in gastric cancer. | 2.81e-05 | 2 | 185 | 2 | 33593829 | |
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 10358032 | ||
| Pubmed | Receptor-interacting protein kinases modulate noise-induced sensory hair cell death. | 2.81e-05 | 2 | 185 | 2 | 24874734 | |
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 25674983 | ||
| Pubmed | RIP1/RIP3 binding to HSV-1 ICP6 initiates necroptosis to restrict virus propagation in mice. | 2.81e-05 | 2 | 185 | 2 | 25674982 | |
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 20413098 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 8406479 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 31227597 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 37089942 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 28816233 | ||
| Pubmed | Cis-acting regulatory elements regulating CYP3A4 transcription in human liver. | 2.81e-05 | 2 | 185 | 2 | 32301865 | |
| Pubmed | 3.14e-05 | 12 | 185 | 3 | 30451870 | ||
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | MMS22L BRPF3 CYP3A4 CYP3A43 SEC24A SPTBN1 BAZ1B LAMC3 FRYL CHD7 OGDH NF1 KLHL30 TET1 VPS13A RNF10 DAAM2 KAZN FHIP1A | 3.85e-05 | 1242 | 185 | 19 | 30973865 |
| Interaction | YWHAG interactions | RALGAPA1 HNF1A SHROOM3 MAP2 MAP4K3 DISC1 SEC24A SPTAN1 SPTBN1 HECTD4 MCM5 FRYL SAMSN1 MAP3K6 RSRC1 MPRIP CEP350 CFD NF1 TRIM67 MAP4K5 TET1 MACF1 MTBP KIF5A WASF1 PCM1 PHLDB2 SON | 2.54e-06 | 1248 | 182 | 29 | int:YWHAG |
| Interaction | NTAN1 interactions | 4.32e-06 | 13 | 182 | 4 | int:NTAN1 | |
| Interaction | ANK1 interactions | 1.12e-05 | 56 | 182 | 6 | int:ANK1 | |
| Interaction | ANKRD20A4P interactions | 1.42e-05 | 6 | 182 | 3 | int:ANKRD20A4P | |
| Interaction | YWHAB interactions | RALGAPA1 HNF1A SHROOM3 MAP2 SEC24A SPTAN1 SPTBN1 HECTD4 FRYL SAMSN1 NEB SHOC2 MPRIP CEP350 CFD NF1 TRIM67 MACF1 MTBP KIF5A WASF1 PCM1 PHLDB2 SON | 1.52e-05 | 1014 | 182 | 24 | int:YWHAB |
| Interaction | YWHAH interactions | RALGAPA1 LGMN SHROOM3 MAP2 SEC24A SPTAN1 SPTBN1 HECTD4 FRYL SAMSN1 MAP3K6 MPRIP CEP350 SNCAIP NF1 TRIM67 SLF2 TET1 RNF10 MACF1 MTBP KIF5A WASF1 PCM1 PHLDB2 | 2.03e-05 | 1102 | 182 | 25 | int:YWHAH |
| Interaction | ANKRD20A2P interactions | 2.47e-05 | 7 | 182 | 3 | int:ANKRD20A2P | |
| Interaction | KALRN interactions | 2.64e-05 | 96 | 182 | 7 | int:KALRN | |
| Interaction | MRPS25 interactions | TACO1 ERCC6 ZNF460 MAP4K3 DDX56 CEP76 ZFC3H1 ZBTB7B CFD TRIM67 AATF | 3.49e-05 | 269 | 182 | 11 | int:MRPS25 |
| Interaction | SIRT7 interactions | COL5A1 SPTAN1 SPTBN1 SPTBN2 BAZ1B SRP72 DHX57 MCM5 DDX56 FRYL CHD7 UBE2O NF1 GEMIN4 MACF1 AATF PCM1 TP53BP1 SON | 4.60e-05 | 744 | 182 | 19 | int:SIRT7 |
| Interaction | RTL1 interactions | 5.85e-05 | 9 | 182 | 3 | int:RTL1 | |
| GeneFamily | EF-hand domain containing|Spectrins | 9.07e-06 | 7 | 117 | 3 | 1113 | |
| GeneFamily | Neuroblastoma breakpoint family | 1.34e-05 | 23 | 117 | 4 | 662 | |
| GeneFamily | Ankyrin repeat domain containing | ANKRD37 ANKRD20A2P ANKRD20A3P SNCAIP ANKRD20A4P ANKDD1B TRPV6 ANKRD20A1 | 1.79e-04 | 242 | 117 | 8 | 403 |
| GeneFamily | Mitogen-activated protein kinase kinase kinase kinases | 4.10e-04 | 5 | 117 | 2 | 655 | |
| GeneFamily | Cytochrome P450 family 3 | 1.13e-03 | 8 | 117 | 2 | 1002 | |
| GeneFamily | Tudor domain containing | 1.75e-03 | 37 | 117 | 3 | 780 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 5.89e-07 | 180 | 183 | 10 | M8239 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuroepithelial|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.58e-07 | 200 | 184 | 9 | 25f4c051c2e869481f33c22ad54de97efac444ad | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuroepithelial-Proteoglycan-expressing_cell|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.58e-07 | 200 | 184 | 9 | da45a85a4667965b24ba824af871157af5b4cd19 | |
| ToppCell | Control-B_naive-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 5.85e-07 | 171 | 184 | 8 | d18855b24aadea38fd1e4592f945cf15b85e05f1 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.19e-06 | 188 | 184 | 8 | ccddc08121caff958a2b6f9e278a018858af6b4d | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.83e-06 | 199 | 184 | 8 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.90e-06 | 200 | 184 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-06 | 151 | 184 | 7 | 5893a51585a65f1902cf85124a5ed9f02b4eb82a | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-06 | 151 | 184 | 7 | 771224e0d6fccfa4225b3adccd7bc22a89a40793 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 5.99e-06 | 166 | 184 | 7 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-Pleural_Mac|Myeloid_cells / Location, Cell class and cell subclass | 6.47e-06 | 168 | 184 | 7 | 8697b40b2ec2cce68ef3beb4792eb3eff29be053 | |
| ToppCell | normal_Lung-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 7.00e-06 | 170 | 184 | 7 | d69c0ea4cb6b204f19d0a5d2164afb42184779ac | |
| ToppCell | Basal_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 8.14e-06 | 174 | 184 | 7 | a0060be3940043015dcc49a5157de5541aed24a1 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.30e-05 | 187 | 184 | 7 | c8278525b3e1d3f3f4defcaf109cce22dd2e157a | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_3|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.39e-05 | 189 | 184 | 7 | 99b01893da9f9f7c9528afaffad178285211738b | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.60e-05 | 193 | 184 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)|Adult / Lineage, Cell type, age group and donor | 1.60e-05 | 193 | 184 | 7 | 31c0978ba78c9516d498aec0798902e57555e557 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-05 | 195 | 184 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-05 | 195 | 184 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.82e-05 | 197 | 184 | 7 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | Bronchial-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.94e-05 | 199 | 184 | 7 | 929f809579368201331d9099d8904b6e3c41797b | |
| ToppCell | Bronchial-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.94e-05 | 199 | 184 | 7 | 854628ce91068093c14bd4d45ba38c41469f3549 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuroepithelial|5w / Sample Type, Dataset, Time_group, and Cell type. | 2.01e-05 | 200 | 184 | 7 | 69707f9576d326a06faac49701ef5cd632e760f6 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuroepithelial-Proteoglycan-expressing_cell|5w / Sample Type, Dataset, Time_group, and Cell type. | 2.01e-05 | 200 | 184 | 7 | f94381d0a3b5b81cdbb13b75fc0e4910cbd70382 | |
| ToppCell | Sepsis-URO-Myeloid-cDC1|URO / Disease, condition lineage and cell class | 2.01e-05 | 200 | 184 | 7 | c5ca81218be40b30e2f9252c1a004cb95d988447 | |
| ToppCell | droplet-Spleen-nan-18m-Hematologic-erythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.59e-05 | 90 | 184 | 5 | 85e5280b5b7d79fed3d356070843a26b50af944b | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_3|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.55e-05 | 155 | 184 | 6 | e1a20e88b9c0eaf7ca7004acc0eda096d1588563 | |
| ToppCell | Control-B_naive-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.55e-05 | 155 | 184 | 6 | 0a78d1cab2bdba2dc8a74cdf35b5a0192370c4b5 | |
| ToppCell | IIF-Lymphocyte-T_NK-ILC|IIF / Disease, Lineage and Cell Type | 5.24e-05 | 159 | 184 | 6 | 55e4f21548f480ca414c00cbff5ec3b13bafd271 | |
| ToppCell | CV-Mild-4|Mild / Virus stimulation, Condition and Cluster | 5.43e-05 | 160 | 184 | 6 | 2e24f8de5086b086863d3bf4d9afbd9bc93f4d5e | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.62e-05 | 161 | 184 | 6 | 58381131e651744b5141b202f9d6063f55432db5 | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.81e-05 | 162 | 184 | 6 | 08ee7ae56e4927874515c47adc86dd845bf29a26 | |
| ToppCell | facs-Lung-EPCAM-3m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.22e-05 | 164 | 184 | 6 | 1d0d88132baaa3154c3e6e4ef0aff795afab08a2 | |
| ToppCell | facs-Lung-EPCAM-3m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.22e-05 | 164 | 184 | 6 | bd2e10b015d5e6a338675500ec5d81dc39583b3e | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.22e-05 | 164 | 184 | 6 | a764b79a127c8f360af0b79a1da64658badf0dfa | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.59e-05 | 170 | 184 | 6 | c1f7f1bb8865e954bb499963d82bb51923d5d8d6 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 7.59e-05 | 170 | 184 | 6 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | wk_20-22-Mesenchymal-Chondrocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.84e-05 | 171 | 184 | 6 | d2938639e9a7c349e5a6ec61724222f9d127c89f | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.10e-05 | 172 | 184 | 6 | eba1568d4307e91c94fc616549057cbed8df5840 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l44|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.36e-05 | 173 | 184 | 6 | b6bb2a136a40f0946bbcde8d5972d3f059d080c7 | |
| ToppCell | COVID-19-kidney-PCT-S3-2|kidney / Disease (COVID-19 only), tissue and cell type | 8.63e-05 | 174 | 184 | 6 | 5aa2fb631505600f37d2b87b02def7be139dc262 | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.19e-05 | 176 | 184 | 6 | a9e77681bcd36c382d53eb6f771349d55f98d744 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.48e-05 | 177 | 184 | 6 | 8abdf1d970b2f15e17e185f3e612dd5065c88757 | |
| ToppCell | Endothelial-Endothelial-C|Endothelial / shred on cell class and cell subclass (v4) | 9.48e-05 | 177 | 184 | 6 | b5b9278dfd76b1aacd88e5fe86e91a2c9b565f87 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.78e-05 | 178 | 184 | 6 | 185b44700f06ec58b3c09c80520502166c965fd6 | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.78e-05 | 178 | 184 | 6 | b4e15c176875cd226854a0019495309d02730c42 | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 179 | 184 | 6 | 7e6da098976c7801d31dcc0201f813d2bc8b07fc | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_3|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.01e-04 | 179 | 184 | 6 | f378307eb20f002450c748b7be2289d6db2fcbcb | |
| ToppCell | Control-Myeloid-Dendritic_cells|Control / group, cell type (main and fine annotations) | 1.04e-04 | 180 | 184 | 6 | 25ad95c3c30e3b82abe93bd77ba003f5c2241f7c | |
| ToppCell | facs-Marrow-B-cells-18m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 180 | 184 | 6 | 7368ab31c3273374ef260f0d710d4eea83cbc4a2 | |
| ToppCell | droplet-Lung-LUNG-30m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 183 | 184 | 6 | 3991830726d05cf19606d540de04093985b7bdeb | |
| ToppCell | wk_20-22-Mesenchymal-Chondrocyte-intermediate_chondrocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.14e-04 | 183 | 184 | 6 | 1464b5c4425e8776c4aeb4d2b560481d4bf13931 | |
| ToppCell | droplet-Lung-LUNG-30m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 183 | 184 | 6 | cc844f54c7564bf432b179ca63bc7c4b9b8cfdd9 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 184 | 184 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | Control-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | 1.17e-04 | 184 | 184 | 6 | c6affa0b12510363258f65e46bf2d47bf4a8e75f | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 184 | 184 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 184 | 184 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | Healthy/Control-B_memory|World / Disease group and Cell class | 1.17e-04 | 184 | 184 | 6 | 9e1879d86b535ede9b47deb0752e291f987a5d5e | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 184 | 184 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 1.17e-04 | 184 | 184 | 6 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.21e-04 | 185 | 184 | 6 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 185 | 184 | 6 | 05bc89a566b0db90ae06506e067190a4739a0974 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.24e-04 | 186 | 184 | 6 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 187 | 184 | 6 | ddfc2d1d9fcc3d8e4d3d015576bb17eebf44ada9 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.28e-04 | 187 | 184 | 6 | d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2 | |
| ToppCell | COPD-Stromal-Pericyte|Stromal / Disease state, Lineage and Cell class | 1.28e-04 | 187 | 184 | 6 | 406ecd1dabb3ed8d871aef159f7bd1e383434953 | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.28e-04 | 187 | 184 | 6 | 39b99f46b723f7f3c44880d7fe8642cbad558b8a | |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | 1.32e-04 | 188 | 184 | 6 | df1fd0819d301679f3c9ea404e942e39095912eb | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-Plasma_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.32e-04 | 188 | 184 | 6 | 34873972dff9284dfcd26bb698c9d1df007f1cbb | |
| ToppCell | Healthy/Control-B_memory|Healthy/Control / Disease group and Cell class | 1.32e-04 | 188 | 184 | 6 | 3aff07f77b2b15e7a30e47b30115178abe64474e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-04 | 189 | 184 | 6 | 8ff3c3232eff9de4b5c9b22ecb82bc509d773f58 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.36e-04 | 189 | 184 | 6 | ca3a04c202afc32aa11d17154066ef7dc6d01405 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.40e-04 | 190 | 184 | 6 | f573fef3762a30c38cf8fa7f45df0ffbb49dc873 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.40e-04 | 190 | 184 | 6 | 2d54fca50593fbd11fe13fc2bfaf937a05db776d | |
| ToppCell | (1)_T_cells-(1)_T_CD4_reg|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.40e-04 | 190 | 184 | 6 | ff42af092173c2d4472bb9a02f5a334c272e05a0 | |
| ToppCell | Control-Myeloid-Transitioning_MDM|Control / group, cell type (main and fine annotations) | 1.40e-04 | 190 | 184 | 6 | d6fd8c23cde4a10cc1517b6899a5a855fdfff2e2 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.40e-04 | 190 | 184 | 6 | 30b50d183d7649146eb1e79b47ba897355f1998a | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.40e-04 | 190 | 184 | 6 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | COPD-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | 1.44e-04 | 191 | 184 | 6 | 3480e6d27dd4291765bbbb2acdb6a2e4f02c8085 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-04 | 192 | 184 | 6 | fd08ae787e936cfdb1ab8f19b0fd63005b462709 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.52e-04 | 193 | 184 | 6 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | Immune-interstitial_macrophage_(C1Q_positive)|World / Lineage, Cell type, age group and donor | 1.52e-04 | 193 | 184 | 6 | 64d598162a256ac6c9f8280c8a9133661dfbb10f | |
| ToppCell | RA-08._Macrophage|World / Chamber and Cluster_Paper | 1.52e-04 | 193 | 184 | 6 | 5fd22db1825d105709fcc0aa4955c99a117e3c82 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.52e-04 | 193 | 184 | 6 | c3522693439c23830d8a3f20854539ccb7a666e0 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-04 | 194 | 184 | 6 | 4579b4a44f7c731553a284843c296866027d7c0e | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D231|Adult / Lineage, Cell type, age group and donor | 1.56e-04 | 194 | 184 | 6 | 800d3d7a9e864d2d6a100a4e4af22f45d5790a8d | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.56e-04 | 194 | 184 | 6 | 663e7e7fe48157e808b4f1a0ea6ad41944e857a2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-04 | 194 | 184 | 6 | 1dce6d4b6ac41f80677e3e4c335a4f383bd76f85 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.61e-04 | 195 | 184 | 6 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.61e-04 | 195 | 184 | 6 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | distal-Hematologic-Classical_Monocyte-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.61e-04 | 195 | 184 | 6 | 32c34741e35006b7238896fd04a497011297dd22 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.61e-04 | 195 | 184 | 6 | e525b69145059b66417589601f7109af63730f3a | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.61e-04 | 195 | 184 | 6 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_activated|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.61e-04 | 195 | 184 | 6 | ecf7d9856a5b507ec17c325c9a772dc5a184bc8e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-04 | 195 | 184 | 6 | 34a9462f4e843f3065cc58c17ad71c1b5b836ae1 | |
| ToppCell | ASK452|World / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.61e-04 | 195 | 184 | 6 | 7efd9d3a3f5e7dfe9698a4143ce4a0f9bf3a862c | |
| ToppCell | Smart-seq2-thymus_(Smart-seq2)-myeloid-myeloid_macrophage|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.70e-04 | 197 | 184 | 6 | e3349a381723393cd255f202afedd0c99037939b | |
| ToppCell | Smart-seq2-thymus_(Smart-seq2)-myeloid-myeloid_macrophage-macrophage|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.70e-04 | 197 | 184 | 6 | e567886d69c6ea8dec87019c2ebc593793cb3107 | |
| ToppCell | distal-2-Hematologic-Classical_Monocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.70e-04 | 197 | 184 | 6 | 9a1c9221904ad1e46e64e3785516804e87128adc | |
| ToppCell | distal-Hematologic-IGSF21+_Dendritic-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.70e-04 | 197 | 184 | 6 | e77c91f5a1f5a292eda41abf3b1e31180f2c61e1 | |
| ToppCell | distal-3-Hematologic-IGSF21+_Dendritic|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.70e-04 | 197 | 184 | 6 | 52e9dc35dd8cc2605fa4894bb16bb5c6086faa76 | |
| Disease | neutrophil count, eosinophil count | UBR2 HNF1A EML6 HECTD4 CHD7 ABCA7 NLRP3 SLC45A4 COQ8A MAP4K5 | 5.38e-07 | 213 | 172 | 10 | EFO_0004833, EFO_0004842 |
| Disease | neutrophil count, basophil count | UBR2 HNF1A EML6 HECTD4 CHD7 ABCA7 NLRP3 SLC45A4 COQ8A MAP4K5 | 8.52e-07 | 224 | 172 | 10 | EFO_0004833, EFO_0005090 |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 2.17e-06 | 144 | 172 | 8 | EFO_0004611, EFO_0020943 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 2.96e-05 | 150 | 172 | 7 | EFO_0004611, EFO_0020947 | |
| Disease | neutrophil percentage of leukocytes | PALD1 UBR2 HNF1A CHD7 SHOC2 ABCA7 NLRP3 SLC45A4 UBE2O TMTC3 COQ8A MAP4K5 UBASH3B | 6.45e-05 | 610 | 172 | 13 | EFO_0007990 |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 7.94e-05 | 121 | 172 | 6 | EFO_0008595, EFO_0020943 | |
| Disease | Inherited neuropathies | 8.65e-05 | 40 | 172 | 4 | C0598589 | |
| Disease | hematocrit | RALGAPA1 ZYG11A TDRD15 HNF1A NR2E3 BRPF3 SHROOM3 RIPK3 MAT1A HECTD4 DNAH2 ZBTB7B MPRIP ACSBG1 MAP4K5 FKBP8 TP53BP1 | 9.35e-05 | 1011 | 172 | 17 | EFO_0004348 |
| Disease | Intrahepatic cholestasis of pregnancy | 1.03e-04 | 16 | 172 | 3 | EFO_0009048 | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 1.04e-04 | 127 | 172 | 6 | EFO_0008595, EFO_0020947 | |
| Disease | granulocyte count | 1.29e-04 | 254 | 172 | 8 | EFO_0007987 | |
| Disease | Hypertriglyceridemia | 1.76e-04 | 19 | 172 | 3 | EFO_0004211 | |
| Disease | spinocerebellar ataxia type 5 (implicated_via_orthology) | 2.01e-04 | 4 | 172 | 2 | DOID:0050882 (implicated_via_orthology) | |
| Disease | C-reactive protein measurement | NBPF3 UBR2 TDRD15 HNF1A MMS22L CYP3A4 BAZ1B CCDC168 CHD7 IL18RAP NLRP3 MAP4K5 RAVER2 RNF10 MACF1 PSME3 MAPK6 TP53BP1 | 2.53e-04 | 1206 | 172 | 18 | EFO_0004458 |
| Disease | aspartate aminotransferase measurement | HNF1A SHROOM3 IQGAP2 HECTD4 OBSCN DNAH2 SHOC2 IL18RAP NLRP3 SLC45A4 NF1 MAP4K5 RBPJ KAZN UBASH3B | 2.82e-04 | 904 | 172 | 15 | EFO_0004736 |
| Disease | urate measurement, bone density | TRPM6 FNBP1 COL5A1 KIF6 ABCB5 OGDH DNAH1 EYS MAP4K5 USP40 KAZN PDZD2 | 2.95e-04 | 619 | 172 | 12 | EFO_0003923, EFO_0004531 |
| Disease | factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement | 3.23e-04 | 56 | 172 | 4 | EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791 | |
| Disease | response to platinum based chemotherapy, cytotoxicity measurement | 3.34e-04 | 5 | 172 | 2 | EFO_0004647, EFO_0006952 | |
| Disease | serum alpha-1-antitrypsin measurement | 3.34e-04 | 5 | 172 | 2 | EFO_0005415 | |
| Disease | lactosyl-N-palmitoyl-sphingosine (d18:1/16:0) measurement | 3.34e-04 | 5 | 172 | 2 | EFO_0800429 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 3.58e-04 | 224 | 172 | 7 | EFO_0004530, EFO_0008317 | |
| Disease | triglycerides in IDL measurement | 3.70e-04 | 58 | 172 | 4 | EFO_0022149 | |
| Disease | fibrinogen measurement, factor VII measurement | 3.70e-04 | 58 | 172 | 4 | EFO_0004619, EFO_0004623 | |
| Disease | epiandrosterone sulfate measurement | 4.07e-04 | 25 | 172 | 3 | EFO_0021120 | |
| Disease | cholesterol to total lipids in IDL percentage | 4.22e-04 | 60 | 172 | 4 | EFO_0022233 | |
| Disease | Lissencephaly | 4.99e-04 | 6 | 172 | 2 | C0266463 | |
| Disease | magnesium measurement | 6.06e-04 | 66 | 172 | 4 | EFO_0004845 | |
| Disease | 1-palmitoyl-GPE (16:0) measurement | 6.96e-04 | 7 | 172 | 2 | EFO_0800245 | |
| Disease | cholesteryl ester measurement | 8.09e-04 | 257 | 172 | 7 | EFO_0010351 | |
| Disease | alkaline phosphatase measurement | NBPF3 RALGAPA1 TDRD15 HNF1A SPTBN1 BAZ1B ERGIC2 NLRP3 NF1 SLF2 MAP4K5 RNF10 MACF1 UBASH3B TP53BP1 | 9.27e-04 | 1015 | 172 | 15 | EFO_0004533 |
| Disease | fatty acid measurement | 1.09e-03 | 436 | 172 | 9 | EFO_0005110 | |
| Disease | low density lipoprotein cholesterol measurement, C-reactive protein measurement | 1.11e-03 | 35 | 172 | 3 | EFO_0004458, EFO_0004611 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 1.17e-03 | 200 | 172 | 6 | EFO_0004611, EFO_0020945 | |
| Disease | lactosyl-N-nervonoyl-sphingosine (d18:1/24:1) measurement | 1.18e-03 | 9 | 172 | 2 | EFO_0800517 | |
| Disease | level of Sterol ester (27:1/16:1) in blood serum | 1.18e-03 | 9 | 172 | 2 | OBA_2045190 | |
| Disease | calcium measurement | TRPM6 NBPF3 MAP4K3 SPTBN1 DNAH2 MAP4K5 RBPJ USP40 MACF1 KIF5A UBASH3B | 1.20e-03 | 628 | 172 | 11 | EFO_0004838 |
| Disease | free cholesterol measurement, low density lipoprotein cholesterol measurement | 1.28e-03 | 137 | 172 | 5 | EFO_0004611, EFO_0008591 | |
| Disease | testosterone measurement | TRPM6 HNF1A SHROOM3 TRIM4 CYP3A4 GLYCTK DNAH2 TTC27 BAZ1B CHD7 ZBTB7B NF1 MAP4K5 ANKDD1B MACF1 DAAM2 KAZN | 1.31e-03 | 1275 | 172 | 17 | EFO_0004908 |
| Disease | total blood protein measurement | IQGAP2 MAP4K3 SLC45A4 DNAH1 MAP4K5 RBPJ MACF1 LRRC8B UBASH3B | 1.34e-03 | 449 | 172 | 9 | EFO_0004536 |
| Disease | phosphatidylcholine measurement | 1.44e-03 | 284 | 172 | 7 | EFO_0010226 | |
| Disease | level of Sterol ester (27:1/18:3) in blood serum | 1.47e-03 | 10 | 172 | 2 | OBA_2045193 | |
| Disease | level of Phosphatidylcholine (18:0_22:5) in blood serum | 1.47e-03 | 10 | 172 | 2 | OBA_2045096 | |
| Disease | intermediate density lipoprotein measurement | 1.70e-03 | 87 | 172 | 4 | EFO_0008595 | |
| Disease | follistatin measurement | 1.79e-03 | 11 | 172 | 2 | EFO_0010614 | |
| Disease | lymphocyte percentage of leukocytes | PALD1 UBR2 HNF1A CHD7 IL18RAP ABCA7 NLRP3 UBE2O TMTC3 COQ8A UBASH3B | 1.88e-03 | 665 | 172 | 11 | EFO_0007993 |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 2.01e-03 | 91 | 172 | 4 | EFO_0004611, EFO_0005271 | |
| Disease | triglycerides in large LDL measurement | 2.02e-03 | 43 | 172 | 3 | EFO_0022319 | |
| Disease | red blood cell density measurement | RALGAPA1 ZYG11A HNF1A SHROOM3 SPTBN1 FKBP9 DNAH2 TMTC3 ACSBG1 KLHL30 MAP4K5 MRPL40 UBASH3B | 2.03e-03 | 880 | 172 | 13 | EFO_0007978 |
| Disease | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 2.08e-03 | 303 | 172 | 7 | EFO_0004612, EFO_0020945 | |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 2.12e-03 | 225 | 172 | 6 | EFO_0008317, EFO_0010351 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 2.12e-03 | 225 | 172 | 6 | EFO_0008317, EFO_0020947 | |
| Disease | methionine sulfone measurement | 2.15e-03 | 12 | 172 | 2 | EFO_0800072 | |
| Disease | response to carboplatin, methylcobalamin deficiency type cblE, response to antineoplastic agent | 2.15e-03 | 12 | 172 | 2 | GO_0097327, GO_0097328, MONDO_0009354 | |
| Disease | alcohol consumption measurement, alcohol drinking | 2.15e-03 | 12 | 172 | 2 | EFO_0004329, EFO_0007878 | |
| Disease | cortical surface area measurement | TRPM6 PALD1 KIF6 SHROOM3 IQGAP2 MAP2 SPTBN1 LAMC3 FRYL CHD7 SLC45A4 MPRIP CSGALNACT2 MACF1 MAPK6 TANGO6 PDZD2 | 2.31e-03 | 1345 | 172 | 17 | EFO_0010736 |
| Disease | fibrinogen measurement, tissue plasminogen activator measurement | 2.31e-03 | 45 | 172 | 3 | EFO_0004623, EFO_0004791 | |
| Disease | fibrinogen measurement, plasminogen activator inhibitor 1 measurement | 2.31e-03 | 45 | 172 | 3 | EFO_0004623, EFO_0004792 | |
| Disease | saturated fatty acids measurement | 2.31e-03 | 45 | 172 | 3 | EFO_0022304 | |
| Disease | lipid measurement, intermediate density lipoprotein measurement | 2.44e-03 | 96 | 172 | 4 | EFO_0004529, EFO_0008595 | |
| Disease | carbohydrate measurement | 2.46e-03 | 46 | 172 | 3 | EFO_0004998 | |
| Disease | cystatin C measurement | 2.57e-03 | 402 | 172 | 8 | EFO_0004617 | |
| Disease | serum albumin measurement | HNF1A SHROOM3 MAP4K3 NLRP3 SLC45A4 MAP4K5 RBPJ MACF1 UBASH3B TP53BP1 | 2.59e-03 | 592 | 172 | 10 | EFO_0004535 |
| Disease | mean reticulocyte volume | ZYG11A IQGAP2 DNAH2 NEB ABCA7 CEP350 TMTC3 ACSBG1 MAP4K5 VPS13A INTS4 PCM1 | 2.63e-03 | 799 | 172 | 12 | EFO_0010701 |
| Disease | mean platelet volume | IQGAP2 PCDHGB3 SPTBN1 EML6 FRYL CHD7 SLC45A4 MPRIP CLIC1 MAP4K5 INTS4 UBASH3B ESPL1 PCDHGC3 | 2.70e-03 | 1020 | 172 | 14 | EFO_0004584 |
| Disease | total lipids in lipoprotein particles measurement | 2.78e-03 | 48 | 172 | 3 | EFO_0022309 | |
| Disease | phosphoglycerides measurement | 2.78e-03 | 48 | 172 | 3 | EFO_0022291 | |
| Disease | alpha fetoprotein measurement | 2.83e-03 | 100 | 172 | 4 | EFO_0010583 | |
| Disease | Asbestosis | 2.94e-03 | 14 | 172 | 2 | C0003949 | |
| Disease | Pulmonary Fibrosis - from Asbestos Exposure | 2.94e-03 | 14 | 172 | 2 | C2930617 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 3.10e-03 | 243 | 172 | 6 | EFO_0004612, EFO_0020944 | |
| Disease | triglycerides to total lipids in medium LDL percentage | 3.12e-03 | 50 | 172 | 3 | EFO_0022334 | |
| Disease | cholesteryl esters to total lipids in IDL percentage | 3.12e-03 | 50 | 172 | 3 | EFO_0022247 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 3.15e-03 | 103 | 172 | 4 | EFO_0008595, EFO_0020944 | |
| Disease | total cholesterol measurement, diastolic blood pressure, triglyceride measurement, systolic blood pressure, hematocrit, ventricular rate measurement, glucose measurement, body mass index, high density lipoprotein cholesterol measurement | 3.30e-03 | 51 | 172 | 3 | EFO_0004340, EFO_0004348, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928 | |
| Disease | triglycerides to total lipids in large LDL percentage | 3.30e-03 | 51 | 172 | 3 | EFO_0022331 | |
| Disease | liver volume | 3.37e-03 | 15 | 172 | 2 | EFO_0600048 | |
| Disease | RASopathy | 3.37e-03 | 15 | 172 | 2 | cv:C5555857 | |
| Disease | YKL40 measurement | 3.37e-03 | 15 | 172 | 2 | EFO_0004869 | |
| Disease | lipid metabolism disorder (implicated_via_orthology) | 3.37e-03 | 15 | 172 | 2 | DOID:3146 (implicated_via_orthology) | |
| Disease | myeloid white cell count | UBR2 HNF1A SPTBN1 EML6 HECTD4 CHD7 ABCA7 NLRP3 SLC45A4 UBE2O MAP4K5 RBPJ UBASH3B | 3.48e-03 | 937 | 172 | 13 | EFO_0007988 |
| Disease | episodic memory | 3.49e-03 | 52 | 172 | 3 | EFO_0004333 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 3.68e-03 | 53 | 172 | 3 | C4707243 | |
| Disease | total phospholipids in lipoprotein particles measurement | 3.68e-03 | 53 | 172 | 3 | EFO_0022315 | |
| Disease | triglycerides in HDL measurement | 3.68e-03 | 53 | 172 | 3 | EFO_0022317 | |
| Disease | serum metabolite measurement | NBPF3 RALGAPA1 TDRD15 LGMN HNF1A RIPK1 TRIM4 CYP3A4 CYP3A43 LAMC3 ABCA7 SLC45A4 MAP4K5 | 3.73e-03 | 945 | 172 | 13 | EFO_0005653 |
| Disease | monocyte percentage of leukocytes | UBR2 ZYG11A CHD7 NLRP3 NF1 COQ8A MAP4K5 RBPJ TLR5 LRRC8B UBASH3B | 3.87e-03 | 731 | 172 | 11 | EFO_0007989 |
| Disease | total lipids in medium VLDL | 3.88e-03 | 54 | 172 | 3 | EFO_0022153 | |
| Disease | triglycerides in medium HDL measurement | 3.88e-03 | 54 | 172 | 3 | EFO_0022321 | |
| Disease | triglycerides in medium VLDL measurement | 4.09e-03 | 55 | 172 | 3 | EFO_0022155 | |
| Disease | Ischemic stroke, fibrinogen measurement | 4.09e-03 | 55 | 172 | 3 | EFO_0004623, HP_0002140 | |
| Disease | triglycerides in very large HDL measurement | 4.09e-03 | 55 | 172 | 3 | EFO_0022324 | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 4.11e-03 | 111 | 172 | 4 | EFO_0004530, EFO_0008595 | |
| Disease | response to statin | 4.30e-03 | 56 | 172 | 3 | GO_0036273 | |
| Disease | triglycerides in LDL measurement | 4.30e-03 | 56 | 172 | 3 | EFO_0022320 | |
| Disease | cholesterol to total lipids in large LDL percentage | 4.30e-03 | 56 | 172 | 3 | EFO_0022235 | |
| Disease | response to phenylephrine | 4.34e-03 | 17 | 172 | 2 | EFO_0010152 | |
| Disease | protein C measurement | 4.34e-03 | 17 | 172 | 2 | EFO_0004633 | |
| Disease | oral motor function measurement | 4.34e-03 | 17 | 172 | 2 | EFO_0021793 | |
| Disease | heel bone mineral density, urate measurement | 4.37e-03 | 182 | 172 | 5 | EFO_0004531, EFO_0009270 | |
| Disease | free cholesterol measurement | 4.38e-03 | 113 | 172 | 4 | EFO_0008591 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ILHADIKPDNILVNE | 811 | Q13523 | |
| AVILLEHGANPNLKD | 116 | Q5TYW2 | |
| GAHIEALDKDNNTPL | 156 | Q5TYW2 | |
| LQLVALDADTINHPA | 316 | Q02641 | |
| NECIAQLKDLLPEHL | 61 | Q9C0J9 | |
| PLDEIKEAANAANIH | 1121 | Q2M3G0 | |
| AVILLEHGANPNLKD | 116 | Q4UJ75 | |
| GAHIEALDKDNNTPL | 156 | Q4UJ75 | |
| SQKELDELLNCLHPQ | 996 | Q9UIG0 | |
| NPLDGTEKIAIDHNQ | 231 | Q96RQ1 | |
| AVILLEHGANPNLKD | 116 | A0PJZ0 | |
| THLLPENENELEKFI | 161 | Q8NEA5 | |
| EVNENILHKPSILQE | 121 | Q9NX38 | |
| TLDLLQEKDPAHIFA | 601 | Q9ULD4 | |
| DELTPFLLAVHEQKQ | 181 | Q6NSI1 | |
| HLKADPDNLQALHTL | 596 | O15484 | |
| APDQQHLSTEDLIKA | 41 | Q8TAP6 | |
| SQKADLEEEPLLHNS | 201 | Q96AQ1 | |
| PQKADLEEEPLLHNS | 201 | Q96LY2 | |
| LDADTINHPAQLIKT | 311 | O00305 | |
| ILNDPELSFLDAHKN | 2116 | Q9P2D1 | |
| EDLEQEKISLHFQLP | 381 | Q9NRI5 | |
| HQTQEALGALLDKEP | 11 | Q86XH1 | |
| AQEPLHSLLEAAEDL | 176 | Q8IZY2 | |
| CSNHEEVSLLEKLQP | 181 | Q8WWL7 | |
| DLNQQDVLGEAPLHK | 56 | Q7Z713 | |
| LPQDSNCQEVHDLLK | 76 | Q9HCJ3 | |
| LKDPEHVEALQDQSQ | 336 | Q9Y5X4 | |
| IADLPHLQDSFVDKL | 766 | Q96HW7 | |
| LADQDIFNAVIKEHP | 291 | Q8N3Y3 | |
| PDQLETLEAQLKAHL | 571 | Q9ULE6 | |
| HDGAPLALQQKLEEV | 256 | Q0D2K2 | |
| AVILLEHGANPNLKD | 116 | Q5SQ80 | |
| GAHIEALDKDNNTPL | 156 | Q5SQ80 | |
| SQPDTIDHDLLLLQL | 106 | P00746 | |
| NLHVADNANLDPVDK | 696 | P0DP91 | |
| SELQHLPEAAKVNLA | 861 | Q86T65 | |
| LAIELLDKVNNPDHS | 281 | Q8IVH8 | |
| EHLALSLFPDVLENK | 431 | O95256 | |
| SHLLNDEDLTQAKPI | 31 | Q6WCQ1 | |
| HNPIVQSLEDLEDQK | 361 | Q674X7 | |
| LPDNHKNALAANIDE | 186 | Q8WWC4 | |
| INNSLILSEDIDPHK | 3081 | Q5T1H1 | |
| QPAEHLQLLEEAAKE | 91 | P33992 | |
| EDEHLLQAISKANPV | 216 | Q9Y217 | |
| FLPSANEHLKEDLNL | 121 | O76003 | |
| DVASHVLDLLNFLKP | 546 | Q6ZRQ5 | |
| DCLLLPHAVLQQEKE | 971 | Q6ZRQ5 | |
| VLDAHLQQDPDAKVA | 41 | P31153 | |
| LHEASENLKNVPLLD | 461 | Q9H9K5 | |
| SIQKLHLADAQDVPN | 256 | Q8IWP9 | |
| NEDVQALKELILHNP | 201 | Q9NY93 | |
| LATHPDVQQKLQEEI | 321 | P08684 | |
| AVLEQELPALAENLH | 1006 | O95382 | |
| ILEDEQPLNSAAHKE | 1876 | Q15154 | |
| LPLADIDHLEQEKQI | 1401 | Q9UHC1 | |
| HALQDLILPENQLEA | 201 | Q9UBM4 | |
| HEPTDVVDKLNDLNS | 541 | Q16659 | |
| HISESQDLDDLLQKP | 1776 | O15018 | |
| DLPETLNELHLDHNK | 226 | P21810 | |
| HIDLSAAPAKQFNLE | 2211 | O94915 | |
| ANLEAQLLSKLDHPA | 76 | Q8NG66 | |
| EDPDQNIHLKNLTLH | 176 | Q6ZMV9 | |
| QISDAVLDAHLKQDP | 36 | Q00266 | |
| LKELENLSPEEAAHQ | 86 | P20823 | |
| AHLEQLKEEELNPDF | 246 | P32456 | |
| EPLNTLINKLIHSDE | 1321 | P23471 | |
| HLIFADSLQEIQPDL | 661 | Q9Y5G1 | |
| ASLPIHIKVLDANDN | 226 | Q9UN70 | |
| HLLSNTILIKPDEND | 456 | Q9Y4D8 | |
| NQHLQALLTPDEPDK | 666 | Q3BBV0 | |
| VVDHPALAFLEENLK | 476 | Q6P9F7 | |
| DTAELLSLENHPAKQ | 741 | Q9UPN3 | |
| DKTPLHANELNEIDA | 3041 | Q5VST9 | |
| FDVALLDLHNPKDSI | 246 | O95302 | |
| AQHLVQKLSPENDDD | 211 | Q9H094 | |
| AQPNVDKLVEDHLAV | 116 | Q02218 | |
| AIHPNTILNSKLEEA | 46 | Q9Y236 | |
| ILKSPDEASQLLDDH | 1186 | Q9P2D7 | |
| AKLAEFLAEHPNVTL | 101 | Q8IUX4 | |
| AVILLEHGANPNLKD | 116 | Q5VUR7 | |
| GAHIEALDKDNNTPL | 156 | Q5VUR7 | |
| APSDLLEFLHSQIDK | 116 | Q8N6G5 | |
| SLVLEHQPDNIKALF | 296 | Q14318 | |
| PEFLKELAALAQEHS | 1011 | Q05DH4 | |
| PSNSHLVLVLDKDLQ | 1886 | Q14674 | |
| KLDLLPENHAVFLQE | 91 | Q96M78 | |
| AAKILIEESQDAPDH | 311 | Q96AV8 | |
| LATHPDVQQKLQEEI | 321 | Q9HB55 | |
| DAQLHELAAELQIPD | 371 | Q8IVS8 | |
| PASLDHKLAEVSQNI | 451 | Q96RU3 | |
| LHLQDQDSVKDAVPD | 781 | Q6P158 | |
| HLLANKFDPKVDDNA | 406 | O95395 | |
| DSLENVPALHLLKEL | 2221 | Q5VT06 | |
| LSIQDDAFINPHLAK | 281 | Q8NI60 | |
| SLNHALELSVPEKVN | 56 | Q96GR2 | |
| AAQPADLLKVLDFHN | 36 | P20908 | |
| TEAADDIINNHLPKL | 201 | Q96NU7 | |
| DLIFESLPENASHKL | 256 | O95260 | |
| VHENALPELAKAEEA | 111 | A6NNW6 | |
| AEDQAKLFPLHQETA | 1016 | Q12840 | |
| LDSLCLHQKLDSQEP | 296 | Q8TB03 | |
| NDDIISLALHPDKTL | 61 | Q6ZMW3 | |
| EEHKVLLEAAPQLSQ | 1466 | Q8NDH2 | |
| EALQPHLAAIATELA | 466 | Q86Y56 | |
| DPDEQLETLHEALKL | 371 | P15882 | |
| NSIQKLHLAENAEPE | 181 | Q9BUN5 | |
| KTDLQELEHIFPNLH | 2061 | Q9C0D2 | |
| ADNAQKDLEEALPAL | 3081 | Q9P225 | |
| LAVELLDKVNNPDNH | 286 | Q9Y4K4 | |
| EAAENLHQLSDKLPA | 146 | Q96DY7 | |
| THEDPQLLEATLAQL | 71 | Q9HB75 | |
| PDAILQAQAADKIHS | 91 | P05120 | |
| FDPQTHDLLLNEKLD | 76 | Q9Y5E3 | |
| LLHPDCKLQVLELDN | 936 | Q96P20 | |
| QAVQFIHKDSADLLP | 31 | Q9NQ35 | |
| QLAEPQSDLEELKHE | 386 | A7E2F4 | |
| ALEELQLESPKLHAE | 146 | Q9NQ50 | |
| PHANETKEILELNSL | 1821 | O60522 | |
| DVALLQLEPHDLSNV | 161 | A6NIE9 | |
| DTSLDIQHVLDKLQP | 221 | B5MCY1 | |
| HLQALLTLDEPDKSQ | 91 | Q3BBV2 | |
| AQHLVQKLSPENDED | 426 | Q5TAG4 | |
| NEHLQALLTPDEPDK | 666 | Q5TAG4 | |
| VQLAEPDLEQAAHLI | 266 | Q9BSH4 | |
| NLHEDIQKLNCNPEL | 371 | O95486 | |
| IKESHLIELNIENPD | 276 | Q9NSI8 | |
| LLLEHQDAIAPEKND | 1221 | Q13576 | |
| QKELHDLLLVSANPS | 306 | Q9Y2K3 | |
| PALILEEKNEANHLG | 36 | A0A1B0GUY1 | |
| NLHLPQTEEAKAEAL | 506 | O14802 | |
| LDLQHNELLDLPDTI | 266 | Q9UQ13 | |
| VHQDKSLADILDPDS | 1676 | Q8TF72 | |
| ISLLPHLAADNLDKI | 331 | Q9Y6H5 | |
| LDEKHEDVPNASNLQ | 1026 | Q8IX21 | |
| KAIELLQEFSDQHPE | 356 | O76094 | |
| LGEKDLPHSVIDNDN | 286 | Q86SQ0 | |
| PENILVDNDFHIKIA | 141 | Q13546 | |
| KLESEHPDQAQAILS | 1021 | Q01082 | |
| PLHEKNLEDNLQSLA | 1606 | Q8NFU7 | |
| LPQAPANAHLKDLDE | 441 | Q9NY61 | |
| LIQDLHLKDLNQPDE | 186 | A6NHY2 | |
| FLLSENVDLHQKVEP | 286 | A6NHY2 | |
| ANAVDPKNDSHVLIE | 256 | Q15642 | |
| NELTLADCNLLPKLH | 171 | O00299 | |
| LDSFLKEPILNIHDL | 41 | P61289 | |
| ETLLDNHLNEAKVPN | 371 | Q5BKX6 | |
| SAELALLLHPVDQAN | 866 | A0JNW5 | |
| LDSEPLLQAIHQLDF | 491 | Q6ZTA4 | |
| SHLALPEEVSLQEQL | 66 | Q14592 | |
| LHQDNLAPGLDSQDK | 321 | O15156 | |
| DFSAPKINLEIELHN | 271 | Q96RL7 | |
| QLPVHEDTQFEALLK | 2011 | Q8N2C7 | |
| QCKLLAQPAENHEEL | 2856 | Q8N2C7 | |
| AHLLDGQDKAEQVLP | 1411 | Q9BX84 | |
| LEPANEIKNLLDEHT | 541 | Q6GYQ0 | |
| HLLNQTDKSHLPEDL | 856 | Q13129 | |
| TLPEAEALLAQHAAL | 1096 | O15020 | |
| NHTEFLDEKIQPILD | 346 | Q6NUQ1 | |
| SNVLLDPELHVKLAD | 146 | Q9Y572 | |
| FAAKLIQEQHPEEEL | 211 | Q13813 | |
| ALEQQLAEEKHTPES | 351 | Q8N5U6 | |
| DGILDLPEQNTIHKD | 71 | Q9NUY8 | |
| LETHALLEKAQALPN | 1146 | Q9C0C9 | |
| EPDDVAKLHAQLALE | 1056 | Q9C0B7 | |
| ESPLLLAAKDNDVQA | 86 | Q9H1D0 | |
| HEQQKLPAATLALEE | 1721 | P21359 | |
| DDLLNLIHAPSVVAK | 376 | A8MT19 | |
| DSPQKLAILDQELEH | 726 | Q12888 | |
| DDNSLAHPNLFIEKA | 296 | Q96IZ7 | |
| TALLDADDPVSQLHK | 271 | Q06330 | |
| HKDQTAALPLAAEET | 116 | P11137 | |
| KHANLLDIPLEDCDQ | 176 | Q96AP4 | |
| HLNPLESIQLELDSV | 201 | Q8N831 | |
| EDVHLENQPKIQELL | 1076 | Q9UI33 | |
| KSHPEVLIAEALAAN | 451 | Q96JP5 | |
| AIDQKPELQLDSLHA | 821 | Q13395 | |
| PELAEDDANLLHKHI | 211 | Q92558 | |
| ASHLPTLEKLAQNID | 221 | Q8TF42 | |
| DDVSAILDNKDLHPS | 31 | Q6ZXV5 | |
| QVAVNLAEDTAHPKL | 306 | Q9C037 | |
| LSHNDLPANLEILDI | 541 | O60602 | |
| TPQEHLTKNLELNDD | 306 | Q6P3X3 | |
| KLFASLVPNDSHEEL | 1391 | Q8IWV8 | |
| HLKVTLAEQDPDELN | 121 | Q6PJE2 | |
| NLKDLQSEEEIDHPL | 331 | Q9NVE5 | |
| KLIELNATAVHADLP | 126 | Q6WRX3 | |
| SDLAFHLLQQKDILP | 271 | Q6WRX3 | |
| QPSLHDLTQDKLTLD | 1011 | O60293 | |
| LDECKIVPQNHSLLE | 126 | Q499Y3 | |
| AKDIHLDLPSNNNLV | 1661 | P18583 | |
| FLKHQAEAQPEDLSL | 156 | O60304 | |
| LAEQLFHPKALAELT | 21 | P57678 | |
| DKQNLEAILHSLPEN | 1556 | Q9Y6N6 | |
| FPNEDLHVKDLNETI | 156 | Q99538 | |
| LSPAAELHLIFNNKE | 1031 | Q5VTT5 | |
| IPDNLEQLHLKEATE | 5881 | P20929 |